Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Lorecivivint Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... (DMOAD). Preclinical studies with vehicle-controlled models suggest that lorecivivint may act through a dual mechanism, providing three key benefits for joint health: promoting cartilage regeneration, slowing cartilage degradation, and reducing inflammation. These effects are increasingly ... Read More
-
Lna043 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... This drug is being explored as a potential groundbreaking disease-modifying therapy for osteoarthritis. LNA043 is part of Novartis’s early investigational efforts aimed at addressing cartilage damage and reducing inflammation associated with osteoarthritis. This drug, which ... Read More
-
Jta-004 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... of hyaluronic acid and plasma protein, substances naturally present in the synovial fluid of joints, along with a fast-acting analgesic. JTA-004 aims to improve joint lubrication, protect cartilage in osteoarthritic joints, and deliver effective pain ... Read More
-
Lab Instrumentation Markets for Pharmaceuticals & Biopharmaceuticals, 2024
... tackling complex cancers and rare diseases, the importance of this industry can’t be overstated. However, creating an ideal therapeutic is not a strait forward process. An illness must be identified, and an early stage of ... Read More
-
Invossa Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... States and globally have demonstrated that INVOSSA can significantly relieve pain, improve mobility, and potentially slow osteoarthritis progression while enhancing joint structure. As an allogeneic, off-the-shelf therapy, it presents a promising alternative to traditional osteoarthritis ... Read More
-
Elixcyte Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... supporting the normal function of damaged chondrocytes. This therapy for osteoarthritis also helps alleviate pain and maintain the normal structure of cartilage. By harnessing the regenerative power of stem cells, ELIXCYTE promotes tissue repair and ... Read More
-
Acute Coronary Syndrome - Market Insight, Epidemiology And Market Forecast - 2034
... US accounted for approximately 37% of the cases, EU4 and the UK countries accounted for around 54%, followed by Japan which represented nearly 9%. DelveInsight’s estimates indicate that in 2023, there were approximately 77,445 diagnosed ... Read More
-
Bronchiectasis - Market Insight, Epidemiology And Market Forecast - 2034
... the forecast period (2024–2034). This growth is primarily driven by rising diagnosed prevalent cases and the introduction of emerging therapies. According to DelveInsight's analysis, it is projected that approximately 41% of the Total Diagnosed Prevalent ... Read More
-
Chronic Heart Failure - Market Insight, Epidemiology And Market Forecast - 2034
... USD 12 billion which is further expected to rise at a CAGR of 2.8% by 2034. In 2023, the diagnosed prevalence of Atherosclerotic Cardiovascular Disease (ASCVD) was highest in the US among the 7MM, accounting ... Read More
-
Eosinophilic Esophagitis - Market Insight, Epidemiology And Market Forecast - 2034
... to grow with a significant CAGR during the forecast period. In 2023, the US accounted for the maximum share of the total market in the 7MM, i.e., approximately 66%. ITP is defined as a decrease ... Read More
-
Mild Cognitive Impairment - Market Insight, Epidemiology And Market Forecast - 2034
... virus infection in the 7MM is expected to increase, driven by increasing Incident population. DelveInsight’s analyst projects that the total Incident Cases of Parainfluenza Virus in 7MM were approximately 2,709,923 in 2023 and these cases ... Read More
-
Parkinson's Disease Market Insight, Epidemiology And Market Forecast - 2034
... the 7MM is expected to increase, driven by better diagnosis and the launch of emerging therapies. DelveInsight’s analysis estimates that among the total diagnosed prevalent cases of PDP in 7MM approximately 52% of cases were ... Read More
-
Europe Next Generation Sequencing Market Report by Products (Instruments, Reagents & Consumables, and Services), Application (Diagnostics, Agriculture and Animal Research, Drug Discovery, Personalized Medicine and Genetic Screening, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), Country and Company Analysis 2024-2032
... Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), Country and Company Analysis 2024-2032 Europe Next Generation Sequencing Market Outlooks Next ... Read More
-
Cntx-4975 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... trans-capsaicin administered via injection directly to the pain site. This innovative treatment harnesses capsaicin’s natural analgesic properties, aiming to provide rapid, long-lasting, and targeted pain relief. CNTX-4975 further works by targeting the TRPV1 receptor, which ... Read More
-
Lupus Nephritis - Market Insight, Epidemiology And Market Forecast - 2034
... kidneys' small blood vessels. IgA nephropathy occurs when an abnormal protein damages the filtering unit (glomerulus) inside the kidneys. It is estimated that 20–40% of people with IgA nephropathy will develop end-stage kidney disease, which ... Read More
-
Myotonic Dystrophy - Epidemiology Forecast - 2034
... continue to rise, with anticipated growth reaching notable levels by 2034. DelveInsight's analysis shows that in 2023, there were approximately 31,290 diagnosed prevalent cases of Myotonic Dystrophy Type 1 and nearly 7,270 cases of Myotonic ... Read More
-
Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2034
... a full or partial extra copy of chromosome 21. This additional genetic material alters development, leading to the physical and intellectual characteristics associated with Down’s syndrome. The market size of Down’s syndrome in 2023 was ... Read More
-
Mild Cognitive Impairment - Epidemiology Forecast - 2034
... thousand cases which is further expected to increase by 2034. In the US, in 2023, ~6,978 thousand people were affected with Alzheimer disease, accounting for the highest number of cases in the 7MM. DelveInsight estimates ... Read More
-
Global Malignant Pleural Mesothelioma Market (2024 Edition): Analysis By Drug Type (Pemetrexed and Combination, Cisplatin, Carboplatin, Gemcitabine, Vinorelbine, Other Drug Types), By Route of Administration, By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030)
... Forecast (2020-2030) Executive Summary Azoth Analytics has released a research report titled “Global Malignant Pleural Mesothelioma Market (2024 Edition)” which provides a Pemetrexed and Combination analysis of the Global Malignant Pleural Mesothelioma industry in terms ... Read More
-
Metabolomics Reagents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
... readjusted size of US$ 61.94 million by 2030 with a CAGR of 13.22% during the forecast period 2024-2030. North American market for Metabolomics Reagents was valued at $ 10.10 million in 2023 and will reach ... Read More
-
United States Next Generation Sequencing Market Report by Products (Instruments, Reagents & Consumables, and Services), Application (Diagnostics, Agriculture and Animal Research, Drug Discovery, Personalized Medicine and Genetic Screening, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), and Company Analysis 2024-2032
... Semiconductor Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), and Company Analysis 2024-2032 United States Next Generation Sequencing Market Size ... Read More
-
Head and Neck Cancer Therapeutics
... is expected to reach US$4.2 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. PD Inhibitors, one of the segments analyzed in the report, is expected to record a 8.4% ... Read More
-
Myotonic Dystrophy Market Insight, Epidemiology And Market Forecast - 2034
... United States accounted for 45% of the cases, while Japan and Germany represented 9% and 18% of the cases, respectively. DelveInsight’s epidemiology model projects that Parkinson’s disease cases in the US included nearly 695 thousand ... Read More
-
Gonorrhea (GN): Competitive Landscape
... the 16 countries covered in GlobalData’s epidemiology forecast. Currently, the GN market contains many innovative therapies developed by big pharma giants. R&D efforts for GN are limited. Currently, 33 molecules are in the pipeline, with ... Read More
-
Amz001 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... sodium, AMZ001 stands out in the osteoarthritis medication landscape due to its targeted approach, offering effective localized pain relief with a single daily application (QD). Its targeted design helps reduce systemic exposure and minimizes the ... Read More
Research Assistance
